tykhr
sign in
free sign up
Telomir Pharmaceuticals, Inc. Common Stock
Biotechnology
Healthcare
TELO
29.76 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
1.57
52 week high
7.84
high
1.60
52 week low
0.00
low
1.51
growth
-80.61 %
previous Close
1.56
P/E ratio
market cap
34.23 M
div yield
0
usd
Mar 2025
qoq
revenue
0.00 %
net incoming
-2.18 M
24.79 %
eps
0.00 %
30.00 %
eps surprise
30.00 %
net profit margin
-217982800.00 %
0.00 %
operating incoming
-2.19 M
24.69 %
net change in cash
-863.13 K
-300.03 %
cash on hand
403 K
-68.17 %
cost of revenue
0.00 %
top